Search results

Page results

• A quick guide to our performance scores
• People with aphasia make significant improvements thanks to intensive programme at UCLH

  People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.

• Return to work

  Sarcoma treatment is often extensive and can impact on a person’s ability to continue in work or return to work. While some people can continue working throughout their cancer treatment, others…

• New drug trialled to protect people with an impaired immune system against Covid-19

  The first UK participant in a portion of a study looking at a new investigational medication for Covid-19 has received their initial dose of the drug at UCLH.

• Research seeking greater understanding of rare blood cancer and how to treat it

  A new research study at UCLH and UCL will investigate how a rare type of blood cancer develops and what types of treatment may be effective for patients.

• $175.5 million for immunotherapy spin-out to develop new treatments

  Achilles Therapeutics, a company built on research at UCLH, UCL Cancer Institute and the Francis Crick Institute has successfully raised $175.5 million through its initial public offering in the United States.

• Welcome to the new members of the children and young people's diabetes team

  We are excited to announce that we have some new additions to the team. Welcome to Melissa Millson and Emilia (Millie) Jewitt, who have joined the nursing team and to Charlotte Yarnton, who has…

• New ‘Guide to living with Sickle Cell Disorder’ launched by the Red Cell Network

  It is with great pleasure and excitement that we share with you news of an excellent new resource that can be used across the UK for people living with Sickle Cell Disorder.

• Increase in delirium, rare brain inflammation and stroke linked to COVID-19

  Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.

• Researchers to see if sniffer dogs can detect COVID-19

  Could dogs offer quick and effective diagnosis of COVID-19?